In vitro effect of actinomycin D on human neutrophil function

Area of Science:

• Immunology
• Cell Biology
• Pharmacology

Background:

• Neutrophils are critical immune cells for combating bacterial infections.
• Understanding the impact of pharmacological agents on neutrophil function is essential for clinical applications.

Purpose of the Study:

• To investigate the effects of Actinomycin D (ACT-D) on key human neutrophil functions.
• To assess ACT-D's impact on chemotaxis, oxidative burst, phagocytosis, and intracellular killing.

Main Methods:

• Human neutrophils were pretreated with varying concentrations of ACT-D.
• Neutrophil chemotaxis was assessed using fMLP as a chemoattractant.
• Chemiluminescence (CL), superoxide (O2-) production, phagocytosis, and intracellular killing of Salmonella enteritidis were measured.

Main Results:

• ACT-D (1-10 µg/ml) significantly reduced neutrophil chemotaxis towards fMLP.
• ACT-D pretreatment also depressed phorbol myristate acetate-induced CL and superoxide production.
• While phagocytic uptake was unaffected, ACT-D significantly impaired intracellular bacterial killing (P < 0.01).

Conclusions:

• Actinomycin D profoundly impairs human neutrophil-mediated intracellular bacterial killing, likely via effects on respiratory burst activity.
• ACT-D also significantly inhibits directed neutrophil migration (chemotaxis).
• Neutrophil viability remained high (>98%) even at tested ACT-D concentrations.